Hysingla ER 40 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FJH7Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,710
Award facts
- Contract value 100% obligated
- $1,709.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 14, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,709.86 to AmerisourceBergen Drug Corp for the supply of Hysingla ER 40 mg tablets (60-count package). This non-set-aside, firm fixed-price contract is scheduled for completion by January 15, 2026, with performance to occur at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), also holds an expanded IDC with DLA valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Through these contracts, AmerisourceBergen supplies an extensive portfolio of medications across multiple therapeutic domains, including specialty drugs, brand-name and generic medications, vaccines, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FJH7Z?
SPE2DR26FJH7Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FJH7Z worth?
The government has obligated $1,710 on SPE2DR26FJH7Z.
Is contract SPE2DR26FJH7Z an order under another contract?
Yes. SPE2DR26FJH7Z is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJH7Z competed?
The extent of competition for SPE2DR26FJH7Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award